Home › Funds › Point72 Asset Management › ATRA
Point72 Asset Management position in ATRA
ATARA BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2026)687.72K sh
Reported value held$7.90M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 2.32M | $41.50M | New |
| Q4 2021 | 4.61M | $72.71M | Add |
| Q1 2022 | 4.20M | $39.05M | Reduce |
| Q2 2022 | 3.93M | $30.60M | Reduce |
| Q3 2022 | 30.00K | $113.00K | Reduce |
| Q1 2023 | 27.26K | $79.05K | New |
| Q2 2023 | 572.23K | $921.29K | Add |
| Q3 2023 | 555.00K | $821.40K | Reduce |
| Q4 2025 | 18.30K | $330.98K | New |
| Q1 2026 | 194.26K | $918.87K | Add |
| Q2 2026 | 687.72K | $7.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ATRA
- Vanguard Group 225.94K sh · $4.09M · Q4 2025
- BlackRock Inc 84.45K sh · $969.54K · Q2 2026
- Geode Capital Management 75.13K sh · $862.92K · Q2 2026
- Northern Trust Corp 16.59K sh · $190.47K · Q2 2026
- Fidelity Management & Research (FMR) 16.24K sh · $186.41K · Q2 2026
- Millennium Management 12.68K sh · $145.57K · Q2 2026
- Citadel Advisors 10.16K sh · $116.62K · Q2 2026
- Morgan Stanley 9.18K sh · $105.37K · Q2 2026
- UBS Group AG 3.98K sh · $45.68K · Q2 2026
- Wells Fargo & Co 251 sh · $2.88K · Q2 2026
- JPMorgan Chase & Co 216 sh · $2.41K · Q2 2026